1-5 of 5
Michael Hallek
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-term outcomes of chemoimmunotherapy with obinutuzumab/chlorambucil in chronic lymphocytic leukemia

Open Access
Clinical Trials & Observations
Valentin Goede, Kirsten Fischer, Sandra Robrecht, Adam Giza, Martin J. S. Dyer, Michael J. Eckart, Lothar Mϋller, Lukáš Smolej, Nadine Kutsch, Anna-Maria Fink, Stephan Stilgenbauer, Michael Hallek
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2431–2435.
https://doi.org/10.1182/bloodadvances.2024014875
Published: 2025
Includes: Supplemental data
Journal Articles

Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis

Open Access
Tim Richardson, Daniel Schütte, Guido Kobbe, Ben-Niklas Baermann, Tobias A. W. Holderried, Friederike Schmitz, Martina Crysandt, Michael Hallek, Christoph Scheid, Udo Holtick, Oliver A. Cornely, Jannik Stemler, Sibylle C. Mellinghoff
Journal: Blood Advances
Blood Adv (2025) 9 (6): 1370–1375.
https://doi.org/10.1182/bloodadvances.2024015008
Published: 2025
Journal Articles

Six-year follow-up and subgroup analyses of a phase 2 trial of venetoclax for del(17p) chronic lymphocytic leukemia

Free
Clinical Trials & Observations
Stephan Stilgenbauer, Eugen Tausch, Andrew W. Roberts, Matthew S. Davids, Barbara Eichhorst, Michael Hallek, Peter Hillmen, Christof Schneider, Johannes Schetelig, Sebastian Böttcher, Arnon P. Kater, Yanwen Jiang, Michelle Boyer, Relja Popovic, Majd T. Ghanim, Michael Moran, Wendy J. Sinai, Xifeng Wang, Nabanita Mukherjee, Brenda Chyla, William G. Wierda, John F. Seymour
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1992–2004.
https://doi.org/10.1182/bloodadvances.2023011741
Published: 2024
Includes: Supplemental data
Journal Articles

SARS-CoV-2–neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphoma

Free
Clinical Trials & Observations
Jakob J. Malin, Veronica Di Cristanziano, Carola Horn, Elisabeth Pracht, Jorge Garcia Borrega, Eva Heger, Elena Knops, Rolf Kaiser, Boris Böll, Clara Lehmann, Norma Jung, Peter Borchmann, Gerd Fätkenheuer, Florian Klein, Michael Hallek, Jan Rybniker
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1580–1584.
https://doi.org/10.1182/bloodadvances.2021006655
Published: 2022
Includes: Supplemental data
Journal Articles

Constitutive activation of Lyn kinase enhances BCR responsiveness, but not the development of CLL in Eµ-TCL1 mice

Free
Viktoria Kohlhas, Michael Hallek, Phuong-Hien Nguyen
Journal: Blood Advances
Blood Adv (2020) 4 (24): 6106–6116.
https://doi.org/10.1182/bloodadvances.2020002584
Published: 2020
Includes: Supplemental data